Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFIX
|
ENSG00000008441.12 | nuclear factor I X |
NFIB
|
ENSG00000147862.10 | nuclear factor I B |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_14238711_14238862 | NFIB | 57989 | 0.154387 | 0.97 | 1.7e-05 | Click! |
chr9_13750451_13750602 | NFIB | 430265 | 0.006479 | 0.96 | 2.7e-05 | Click! |
chr9_14212321_14212472 | NFIB | 31599 | 0.243632 | 0.95 | 8.6e-05 | Click! |
chr9_14220395_14220546 | NFIB | 39673 | 0.214392 | 0.95 | 8.9e-05 | Click! |
chr9_14278981_14279132 | NFIB | 28956 | 0.218569 | 0.95 | 8.9e-05 | Click! |
chr19_13147816_13148089 | NFIX | 12141 | 0.098762 | 0.95 | 7.0e-05 | Click! |
chr19_13145325_13145476 | NFIX | 9589 | 0.101571 | 0.90 | 8.3e-04 | Click! |
chr19_13142288_13142439 | NFIX | 6552 | 0.107272 | 0.90 | 8.5e-04 | Click! |
chr19_13155299_13155450 | NFIX | 19563 | 0.091042 | 0.89 | 1.3e-03 | Click! |
chr19_13137841_13137992 | NFIX | 2105 | 0.178681 | 0.87 | 2.2e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_54896290_54897472 | 3.61 |
PPAP2A |
phosphatidic acid phosphatase type 2A |
66003 |
0.11 |
chr15_52386582_52387272 | 3.58 |
CTD-2184D3.5 |
|
5793 |
0.16 |
chr6_35393359_35394053 | 3.57 |
FANCE |
Fanconi anemia, complementation group E |
26432 |
0.15 |
chr2_43152776_43153425 | 3.48 |
HAAO |
3-hydroxyanthranilate 3,4-dioxygenase |
133368 |
0.05 |
chr17_40673744_40674238 | 3.37 |
ENSG00000265611 |
. |
7785 |
0.08 |
chr1_208381209_208381624 | 3.18 |
PLXNA2 |
plexin A2 |
36249 |
0.24 |
chr18_32229938_32230237 | 3.14 |
DTNA |
dystrobrevin, alpha |
29414 |
0.24 |
chr1_152155849_152156120 | 3.07 |
FLG-AS1 |
FLG antisense RNA 1 |
5843 |
0.17 |
chr14_76287931_76288578 | 3.07 |
RP11-270M14.4 |
|
15300 |
0.24 |
chr7_137643245_137643895 | 2.98 |
AC022173.2 |
|
5476 |
0.23 |
chr15_40395055_40395567 | 2.93 |
BMF |
Bcl2 modifying factor |
2976 |
0.21 |
chr17_79394579_79395078 | 2.88 |
RP11-1055B8.7 |
BAH and coiled-coil domain-containing protein 1 |
10568 |
0.11 |
chr16_11222143_11222802 | 2.80 |
CLEC16A |
C-type lectin domain family 16, member A |
2547 |
0.29 |
chr11_67781609_67782080 | 2.78 |
ALDH3B1 |
aldehyde dehydrogenase 3 family, member B1 |
4054 |
0.13 |
chr15_67055010_67055873 | 2.68 |
SMAD6 |
SMAD family member 6 |
51406 |
0.15 |
chr1_2145701_2146237 | 2.59 |
AL590822.1 |
Uncharacterized protein |
349 |
0.81 |
chr10_80916996_80917718 | 2.58 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
88565 |
0.09 |
chr6_8083142_8083550 | 2.58 |
EEF1E1 |
eukaryotic translation elongation factor 1 epsilon 1 |
14198 |
0.22 |
chr10_95225795_95226087 | 2.57 |
MYOF |
myoferlin |
16010 |
0.19 |
chr8_97603049_97603490 | 2.53 |
SDC2 |
syndecan 2 |
4654 |
0.31 |
chr14_25518403_25519489 | 2.51 |
STXBP6 |
syntaxin binding protein 6 (amisyn) |
149 |
0.98 |
chr11_128077291_128077590 | 2.51 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
297849 |
0.01 |
chr11_15989853_15990583 | 2.50 |
CTD-3096P4.1 |
|
54518 |
0.18 |
chr10_95197392_95197711 | 2.48 |
MYOF |
myoferlin |
44400 |
0.14 |
chr17_36604180_36604649 | 2.48 |
ENSG00000260833 |
. |
3518 |
0.2 |
chr2_12959099_12960371 | 2.48 |
ENSG00000264370 |
. |
82242 |
0.11 |
chr1_208376929_208377080 | 2.45 |
PLXNA2 |
plexin A2 |
40661 |
0.22 |
chr12_52585063_52585443 | 2.45 |
KRT80 |
keratin 80 |
531 |
0.69 |
chr2_47074710_47074982 | 2.43 |
AC016722.3 |
|
5789 |
0.17 |
chr2_65202656_65202807 | 2.43 |
SLC1A4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
12893 |
0.16 |
chr18_7578966_7579266 | 2.41 |
PTPRM |
protein tyrosine phosphatase, receptor type, M |
11299 |
0.29 |
chr12_89555329_89555814 | 2.40 |
ENSG00000238302 |
. |
120491 |
0.06 |
chr10_104387858_104388403 | 2.38 |
TRIM8 |
tripartite motif containing 8 |
16123 |
0.16 |
chr9_127104782_127105372 | 2.37 |
ENSG00000264237 |
. |
7733 |
0.2 |
chr1_15655039_15655600 | 2.35 |
RP3-467K16.7 |
|
6641 |
0.17 |
chr12_66271805_66272278 | 2.35 |
RP11-366L20.2 |
Uncharacterized protein |
3317 |
0.24 |
chr14_101308246_101309004 | 2.34 |
ENSG00000214548 |
. |
7020 |
0.04 |
chr6_52369236_52369469 | 2.34 |
TRAM2 |
translocation associated membrane protein 2 |
72361 |
0.1 |
chr3_50195246_50195978 | 2.33 |
SEMA3F |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
840 |
0.45 |
chr15_99994749_99995202 | 2.33 |
MEF2A |
myocyte enhancer factor 2A |
22395 |
0.18 |
chr4_140958813_140959347 | 2.33 |
RP11-392B6.1 |
|
90089 |
0.09 |
chr18_60118168_60118548 | 2.32 |
ZCCHC2 |
zinc finger, CCHC domain containing 2 |
71882 |
0.1 |
chr9_97567295_97567893 | 2.31 |
ENSG00000252153 |
. |
4650 |
0.2 |
chr6_90021967_90022444 | 2.30 |
GABRR2 |
gamma-aminobutyric acid (GABA) A receptor, rho 2 |
2762 |
0.29 |
chr2_10423040_10423522 | 2.30 |
ENSG00000264030 |
. |
2524 |
0.25 |
chr16_54482153_54482558 | 2.29 |
ENSG00000264079 |
. |
100953 |
0.08 |
chr2_134894417_134895433 | 2.28 |
ENSG00000263813 |
. |
10229 |
0.24 |
chr11_36035998_36036518 | 2.28 |
ENSG00000263389 |
. |
4610 |
0.26 |
chr6_110115771_110116061 | 2.26 |
FIG4 |
FIG4 homolog, SAC1 lipid phosphatase domain containing (S. cerevisiae) |
8707 |
0.29 |
chr2_65085563_65085984 | 2.25 |
ENSG00000199964 |
. |
24482 |
0.15 |
chr1_1207528_1208557 | 2.25 |
UBE2J2 |
ubiquitin-conjugating enzyme E2, J2 |
809 |
0.37 |
chr9_94533727_94534271 | 2.24 |
ENSG00000266855 |
. |
135466 |
0.05 |
chr4_57946942_57947313 | 2.24 |
ENSG00000238541 |
. |
25384 |
0.14 |
chr20_1914315_1914559 | 2.24 |
RP4-684O24.5 |
|
13455 |
0.21 |
chr12_57542255_57543089 | 2.23 |
RP11-545N8.3 |
|
1270 |
0.29 |
chr10_105409169_105409599 | 2.16 |
SH3PXD2A |
SH3 and PX domains 2A |
12078 |
0.17 |
chr5_90592330_90592999 | 2.15 |
ENSG00000199643 |
. |
26120 |
0.23 |
chr19_38526637_38527071 | 2.15 |
ENSG00000221258 |
. |
17751 |
0.17 |
chrX_46303903_46304407 | 2.14 |
KRBOX4 |
KRAB box domain containing 4 |
2137 |
0.41 |
chr18_9017327_9018234 | 2.13 |
NDUFV2 |
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa |
84848 |
0.08 |
chr3_125230252_125231290 | 2.13 |
ENSG00000201800 |
. |
5052 |
0.18 |
chr1_214689137_214689772 | 2.11 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
35112 |
0.22 |
chr3_53270514_53271027 | 2.10 |
TKT |
transketolase |
19246 |
0.13 |
chr6_47209724_47210383 | 2.10 |
TNFRSF21 |
tumor necrosis factor receptor superfamily, member 21 |
67588 |
0.13 |
chr1_16575086_16575400 | 2.10 |
FBXO42 |
F-box protein 42 |
4679 |
0.13 |
chr5_14264414_14265476 | 2.09 |
TRIO |
trio Rho guanine nucleotide exchange factor |
26141 |
0.27 |
chr11_33714452_33714603 | 2.08 |
RP4-541C22.5 |
|
3720 |
0.2 |
chr5_38463728_38464142 | 2.07 |
CTD-2263F21.1 |
|
4474 |
0.2 |
chr17_78801110_78801319 | 2.06 |
RP11-28G8.1 |
|
21782 |
0.2 |
chr1_202251770_202252122 | 2.06 |
ENSG00000239046 |
. |
51154 |
0.1 |
chr7_20238822_20239157 | 2.05 |
MACC1 |
metastasis associated in colon cancer 1 |
14288 |
0.23 |
chr15_81069849_81070080 | 2.03 |
KIAA1199 |
KIAA1199 |
1720 |
0.42 |
chr16_69213504_69213973 | 2.03 |
ENSG00000207083 |
. |
4058 |
0.14 |
chr1_32178967_32179267 | 2.03 |
COL16A1 |
collagen, type XVI, alpha 1 |
9197 |
0.14 |
chr1_203482695_203483217 | 2.02 |
OPTC |
opticin |
17858 |
0.21 |
chr11_47437227_47437644 | 2.02 |
SLC39A13 |
solute carrier family 39 (zinc transporter), member 13 |
5799 |
0.09 |
chr20_48925461_48925757 | 2.00 |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
118233 |
0.05 |
chr1_21066214_21066365 | 2.00 |
RP5-930J4.4 |
|
3191 |
0.17 |
chr7_28076131_28076580 | 1.99 |
JAZF1 |
JAZF zinc finger 1 |
15937 |
0.26 |
chr11_19222231_19222783 | 1.99 |
CSRP3 |
cysteine and glycine-rich protein 3 (cardiac LIM protein) |
1082 |
0.5 |
chr5_81460698_81461288 | 1.98 |
ENSG00000265684 |
. |
86747 |
0.08 |
chr3_72368118_72368657 | 1.98 |
ENSG00000212070 |
. |
56808 |
0.16 |
chr10_5504056_5504535 | 1.97 |
NET1 |
neuroepithelial cell transforming 1 |
15721 |
0.15 |
chr17_36607297_36607925 | 1.97 |
ENSG00000260833 |
. |
321 |
0.87 |
chr2_225085875_225086167 | 1.97 |
ENSG00000211987 |
. |
18252 |
0.28 |
chr6_86168657_86168808 | 1.96 |
NT5E |
5'-nucleotidase, ecto (CD73) |
8905 |
0.27 |
chr9_124038362_124038896 | 1.96 |
RP11-477J21.6 |
|
6379 |
0.15 |
chr10_22723256_22723780 | 1.96 |
RP11-301N24.3 |
|
73417 |
0.1 |
chr10_80936284_80936568 | 1.95 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
107634 |
0.07 |
chr5_95674311_95674759 | 1.95 |
PCSK1 |
proprotein convertase subtilisin/kexin type 1 |
93329 |
0.08 |
chr14_51394554_51395139 | 1.95 |
RP11-218E20.5 |
|
15902 |
0.16 |
chr10_112206935_112207266 | 1.94 |
ENSG00000221359 |
. |
13101 |
0.19 |
chr4_146467395_146467619 | 1.93 |
SMAD1-AS1 |
SMAD1 antisense RNA 1 |
29237 |
0.17 |
chr15_59462353_59462672 | 1.92 |
ENSG00000253030 |
. |
949 |
0.42 |
chr14_75867050_75867708 | 1.92 |
RP11-293M10.6 |
|
27014 |
0.16 |
chr1_61707226_61707507 | 1.91 |
NFIA |
nuclear factor I/A |
110756 |
0.07 |
chr15_40628103_40628665 | 1.91 |
C15orf52 |
chromosome 15 open reading frame 52 |
1857 |
0.16 |
chr10_80732018_80732433 | 1.91 |
ZMIZ1-AS1 |
ZMIZ1 antisense RNA 1 |
10074 |
0.3 |
chr6_127042369_127042728 | 1.90 |
ENSG00000201613 |
. |
131009 |
0.06 |
chr15_63664697_63665270 | 1.90 |
CA12 |
carbonic anhydrase XII |
9051 |
0.26 |
chr7_134133604_134133901 | 1.90 |
AKR1B1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
10142 |
0.26 |
chr1_22231017_22231447 | 1.90 |
HSPG2 |
heparan sulfate proteoglycan 2 |
8429 |
0.18 |
chr2_197343960_197344111 | 1.89 |
HECW2 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 |
113300 |
0.06 |
chr15_31630334_31631466 | 1.89 |
KLF13 |
Kruppel-like factor 13 |
1236 |
0.62 |
chr1_232840317_232840703 | 1.88 |
ENSG00000238382 |
. |
4560 |
0.32 |
chr14_72179521_72179805 | 1.88 |
SIPA1L1 |
signal-induced proliferation-associated 1 like 1 |
94190 |
0.09 |
chr9_94137166_94137359 | 1.87 |
AUH |
AU RNA binding protein/enoyl-CoA hydratase |
13067 |
0.27 |
chr11_35562990_35563282 | 1.87 |
PAMR1 |
peptidase domain containing associated with muscle regeneration 1 |
11288 |
0.25 |
chr20_1349324_1349853 | 1.87 |
RP11-314N13.3 |
|
7322 |
0.15 |
chr22_44433916_44434208 | 1.87 |
PARVB |
parvin, beta |
6817 |
0.26 |
chr7_23375375_23375656 | 1.87 |
MALSU1 |
mitochondrial assembly of ribosomal large subunit 1 |
36696 |
0.16 |
chr9_130597546_130598271 | 1.87 |
ENSG00000222296 |
. |
1587 |
0.18 |
chr15_90205927_90206233 | 1.86 |
PLIN1 |
perilipin 1 |
4791 |
0.14 |
chr1_109938801_109939938 | 1.86 |
SORT1 |
sortilin 1 |
1204 |
0.42 |
chr6_64516560_64517136 | 1.86 |
RP11-59D5__B.2 |
|
119 |
0.98 |
chr16_4103086_4103844 | 1.86 |
RP11-462G12.4 |
|
21452 |
0.2 |
chr11_846397_846885 | 1.86 |
TSPAN4 |
tetraspanin 4 |
556 |
0.49 |
chr18_53664805_53665293 | 1.86 |
ENSG00000201816 |
. |
81776 |
0.12 |
chr6_26157099_26157863 | 1.85 |
HIST1H2BD |
histone cluster 1, H2bd |
868 |
0.26 |
chr1_42420078_42420229 | 1.85 |
HIVEP3 |
human immunodeficiency virus type I enhancer binding protein 3 |
35775 |
0.22 |
chr14_69421781_69422763 | 1.85 |
ACTN1 |
actinin, alpha 1 |
8007 |
0.23 |
chr17_983655_983915 | 1.85 |
ABR |
active BCR-related |
1399 |
0.45 |
chr1_13920635_13920931 | 1.85 |
PDPN |
podoplanin |
8816 |
0.18 |
chr17_55967739_55968110 | 1.85 |
CUEDC1 |
CUE domain containing 1 |
2125 |
0.29 |
chr9_80328804_80329098 | 1.85 |
GNA14 |
guanine nucleotide binding protein (G protein), alpha 14 |
65728 |
0.12 |
chr4_41144342_41144612 | 1.84 |
ENSG00000207198 |
. |
28518 |
0.18 |
chr12_11733293_11733560 | 1.84 |
ENSG00000251747 |
. |
34013 |
0.16 |
chr16_24991701_24992168 | 1.82 |
ARHGAP17 |
Rho GTPase activating protein 17 |
34718 |
0.2 |
chr15_75986048_75986554 | 1.82 |
AC105020.1 |
Uncharacterized protein; cDNA FLJ12988 fis, clone NT2RP3000080 |
15629 |
0.09 |
chr3_128916268_128916630 | 1.82 |
CNBP |
CCHC-type zinc finger, nucleic acid binding protein |
13684 |
0.14 |
chr2_43195529_43196027 | 1.82 |
ENSG00000207087 |
. |
122854 |
0.06 |
chr5_134727254_134728171 | 1.82 |
H2AFY |
H2A histone family, member Y |
7189 |
0.17 |
chr4_86954278_86954588 | 1.82 |
RP13-514E23.1 |
|
19406 |
0.19 |
chr10_29935579_29936697 | 1.81 |
SVIL |
supervillin |
12237 |
0.21 |
chr18_3368211_3368444 | 1.81 |
TGIF1 |
TGFB-induced factor homeobox 1 |
43279 |
0.14 |
chr11_119231679_119232072 | 1.80 |
USP2 |
ubiquitin specific peptidase 2 |
3042 |
0.12 |
chr17_29908199_29908629 | 1.80 |
ENSG00000199187 |
. |
5984 |
0.12 |
chr22_30194899_30195349 | 1.80 |
ASCC2 |
activating signal cointegrator 1 complex subunit 2 |
2967 |
0.2 |
chr16_70737707_70738175 | 1.79 |
VAC14 |
Vac14 homolog (S. cerevisiae) |
3793 |
0.18 |
chr1_200290070_200290348 | 1.79 |
ZNF281 |
zinc finger protein 281 |
88911 |
0.09 |
chr20_43348798_43349109 | 1.78 |
WISP2 |
WNT1 inducible signaling pathway protein 2 |
5067 |
0.15 |
chr4_41147209_41147360 | 1.78 |
ENSG00000207198 |
. |
31325 |
0.17 |
chr3_122803672_122804475 | 1.78 |
PDIA5 |
protein disulfide isomerase family A, member 5 |
17878 |
0.23 |
chr16_2173724_2174217 | 1.78 |
RP11-304L19.2 |
|
4762 |
0.06 |
chr11_73024899_73025487 | 1.78 |
ARHGEF17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
2583 |
0.2 |
chr16_11295567_11296301 | 1.77 |
RMI2 |
RecQ mediated genome instability 2 |
47572 |
0.08 |
chr11_130667785_130667936 | 1.77 |
SNX19 |
sorting nexin 19 |
95909 |
0.08 |
chr2_56102798_56103094 | 1.77 |
EFEMP1 |
EGF containing fibulin-like extracellular matrix protein 1 |
47410 |
0.14 |
chr8_97596258_97596585 | 1.77 |
SDC2 |
syndecan 2 |
752 |
0.76 |
chr12_66262478_66262882 | 1.76 |
ENSG00000211577 |
. |
10887 |
0.18 |
chr1_85808896_85809047 | 1.76 |
ENSG00000264380 |
. |
58678 |
0.09 |
chr9_131960663_131960907 | 1.76 |
RP11-247A12.2 |
|
2809 |
0.19 |
chr11_65210952_65211512 | 1.75 |
ENSG00000245532 |
. |
697 |
0.57 |
chr17_45303007_45303184 | 1.75 |
ENSG00000252088 |
. |
5087 |
0.14 |
chr7_44142325_44142591 | 1.75 |
AEBP1 |
AE binding protein 1 |
1502 |
0.22 |
chr13_30095383_30095797 | 1.75 |
MTUS2-AS1 |
MTUS2 antisense RNA 1 |
31348 |
0.21 |
chr3_182992678_182993398 | 1.74 |
B3GNT5 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
9906 |
0.2 |
chr12_125140025_125140381 | 1.74 |
NCOR2 |
nuclear receptor corepressor 2 |
88193 |
0.09 |
chr12_49181635_49181805 | 1.74 |
ADCY6 |
adenylate cyclase 6 |
1100 |
0.33 |
chr6_52467732_52468424 | 1.74 |
TRAM2 |
translocation associated membrane protein 2 |
26365 |
0.19 |
chr11_65257627_65258285 | 1.74 |
SCYL1 |
SCY1-like 1 (S. cerevisiae) |
34592 |
0.08 |
chr1_226285928_226286144 | 1.73 |
H3F3A |
H3 histone, family 3A |
34358 |
0.13 |
chr19_13133727_13134698 | 1.73 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
593 |
0.58 |
chr10_133760189_133760615 | 1.73 |
PPP2R2D |
protein phosphatase 2, regulatory subunit B, delta |
6869 |
0.26 |
chr17_79679849_79680728 | 1.72 |
SLC25A10 |
solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 |
184 |
0.87 |
chr22_18050241_18050558 | 1.72 |
SLC25A18 |
solute carrier family 25 (glutamate carrier), member 18 |
7249 |
0.19 |
chr14_59827605_59828209 | 1.72 |
ENSG00000252869 |
. |
38834 |
0.18 |
chr12_95510407_95510956 | 1.72 |
FGD6 |
FYVE, RhoGEF and PH domain containing 6 |
68 |
0.98 |
chr17_1971103_1971254 | 1.72 |
HIC1 |
hypermethylated in cancer 1 |
11574 |
0.09 |
chr1_214618510_214618915 | 1.71 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
19434 |
0.26 |
chr9_127042210_127042452 | 1.71 |
NEK6 |
NIMA-related kinase 6 |
6388 |
0.19 |
chr12_122501543_122501754 | 1.71 |
MLXIP |
MLX interacting protein |
14980 |
0.2 |
chr19_33964829_33965004 | 1.71 |
PEPD |
peptidase D |
4074 |
0.3 |
chr2_232505070_232505608 | 1.70 |
ENSG00000239202 |
. |
5645 |
0.2 |
chr8_143757168_143757384 | 1.70 |
PSCA |
prostate stem cell antigen |
4598 |
0.13 |
chr14_80854245_80854396 | 1.70 |
DIO2 |
deiodinase, iodothyronine, type II |
220 |
0.97 |
chr16_575840_576693 | 1.70 |
CAPN15 |
calpain 15 |
1451 |
0.21 |
chr7_23387609_23387938 | 1.70 |
ENSG00000212264 |
. |
48292 |
0.12 |
chr2_43268821_43269030 | 1.70 |
ENSG00000207087 |
. |
49707 |
0.18 |
chr1_31870163_31870721 | 1.70 |
SERINC2 |
serine incorporator 2 |
11970 |
0.15 |
chr4_75072940_75073180 | 1.70 |
AC093677.1 |
Uncharacterized protein |
48975 |
0.12 |
chr2_161276442_161277443 | 1.69 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
4253 |
0.24 |
chr11_57542945_57543611 | 1.69 |
CTNND1 |
catenin (cadherin-associated protein), delta 1 |
5797 |
0.16 |
chr10_29936930_29937596 | 1.69 |
SVIL |
supervillin |
13362 |
0.21 |
chr17_34053021_34053172 | 1.69 |
RASL10B |
RAS-like, family 10, member B |
5572 |
0.12 |
chr1_235133357_235133864 | 1.69 |
ENSG00000239690 |
. |
93677 |
0.08 |
chr7_152010807_152011572 | 1.68 |
KMT2C |
lysine (K)-specific methyltransferase 2C |
66085 |
0.11 |
chr2_43302820_43303049 | 1.68 |
ENSG00000207087 |
. |
15698 |
0.28 |
chr1_95248886_95249289 | 1.67 |
SLC44A3 |
solute carrier family 44, member 3 |
36811 |
0.16 |
chr19_1168901_1169806 | 1.67 |
SBNO2 |
strawberry notch homolog 2 (Drosophila) |
411 |
0.76 |
chr6_116685228_116685657 | 1.67 |
DSE |
dermatan sulfate epimerase |
5568 |
0.22 |
chr10_77718805_77719099 | 1.67 |
ENSG00000215921 |
. |
135416 |
0.05 |
chr5_121305331_121305762 | 1.67 |
SRFBP1 |
serum response factor binding protein 1 |
7890 |
0.28 |
chr21_43352747_43353275 | 1.66 |
C2CD2 |
C2 calcium-dependent domain containing 2 |
6212 |
0.19 |
chr14_100222322_100222621 | 1.66 |
EML1 |
echinoderm microtubule associated protein like 1 |
16815 |
0.21 |
chr22_46942701_46942994 | 1.66 |
RP3-439F8.1 |
|
5455 |
0.21 |
chr13_43890942_43891569 | 1.66 |
ENOX1 |
ecto-NOX disulfide-thiol exchanger 1 |
43958 |
0.21 |
chr9_113508342_113508505 | 1.66 |
MUSK |
muscle, skeletal, receptor tyrosine kinase |
29204 |
0.23 |
chr2_120145220_120145489 | 1.66 |
DBI |
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
20101 |
0.17 |
chr3_132036175_132036576 | 1.66 |
ACPP |
acid phosphatase, prostate |
124 |
0.97 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.2 | GO:0010193 | response to ozone(GO:0010193) |
2.0 | 6.1 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
2.0 | 14.0 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
2.0 | 6.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
1.9 | 7.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.9 | 3.8 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
1.9 | 5.7 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
1.8 | 5.5 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
1.7 | 5.2 | GO:0051834 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
1.6 | 3.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
1.5 | 3.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
1.5 | 4.5 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
1.5 | 5.9 | GO:0007028 | cytoplasm organization(GO:0007028) |
1.4 | 4.2 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
1.4 | 1.4 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
1.4 | 2.7 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.3 | 5.2 | GO:0071731 | response to nitric oxide(GO:0071731) |
1.3 | 3.8 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
1.3 | 1.3 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
1.2 | 2.4 | GO:0060433 | bronchus development(GO:0060433) |
1.2 | 3.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
1.2 | 3.5 | GO:0032347 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
1.2 | 7.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
1.1 | 6.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.1 | 4.5 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
1.1 | 4.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
1.1 | 4.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
1.1 | 4.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
1.0 | 3.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
1.0 | 5.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
1.0 | 4.0 | GO:0097531 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
1.0 | 2.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.0 | 3.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
1.0 | 9.8 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
1.0 | 1.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.0 | 2.9 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.9 | 2.8 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.9 | 1.9 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.9 | 5.6 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.9 | 8.2 | GO:0009629 | response to gravity(GO:0009629) |
0.9 | 2.7 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.9 | 4.6 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.9 | 2.7 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.9 | 3.6 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.9 | 2.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.9 | 0.9 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.9 | 2.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.9 | 2.6 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.9 | 2.6 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.8 | 2.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.8 | 5.0 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.8 | 0.8 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.8 | 4.0 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.8 | 4.8 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.8 | 3.8 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.8 | 3.0 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.8 | 3.0 | GO:0018101 | protein citrullination(GO:0018101) |
0.7 | 3.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.7 | 3.0 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.7 | 3.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.7 | 0.7 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.7 | 2.9 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.7 | 0.7 | GO:0061043 | vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.7 | 1.5 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.7 | 2.2 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.7 | 2.2 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.7 | 5.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.7 | 1.4 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.7 | 1.4 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.7 | 2.9 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.7 | 7.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.7 | 0.7 | GO:0003170 | heart valve development(GO:0003170) heart valve morphogenesis(GO:0003179) |
0.7 | 0.7 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.7 | 1.4 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.7 | 1.4 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.7 | 1.4 | GO:0003308 | heart field specification(GO:0003128) heart induction(GO:0003129) regulation of Wnt signaling pathway involved in heart development(GO:0003307) negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) regulation of heart induction(GO:0090381) regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) |
0.7 | 3.4 | GO:0060174 | limb bud formation(GO:0060174) |
0.7 | 2.7 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.7 | 6.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.7 | 2.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.7 | 2.0 | GO:0071436 | sodium ion export(GO:0071436) |
0.7 | 2.7 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.7 | 2.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.7 | 0.7 | GO:0070254 | mucus secretion(GO:0070254) |
0.7 | 2.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.6 | 3.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.6 | 3.2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.6 | 7.6 | GO:0035329 | hippo signaling(GO:0035329) |
0.6 | 5.0 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.6 | 1.9 | GO:0034653 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.6 | 1.9 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.6 | 2.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.6 | 0.6 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.6 | 1.9 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.6 | 1.9 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.6 | 1.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.6 | 2.5 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.6 | 1.2 | GO:0090190 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.6 | 1.2 | GO:1903170 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.6 | 1.8 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.6 | 1.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.6 | 1.2 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.6 | 1.8 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 3.6 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.6 | 1.8 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.6 | 1.8 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.6 | 1.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.6 | 5.8 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.6 | 1.7 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.6 | 1.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.6 | 1.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.6 | 5.6 | GO:0060612 | adipose tissue development(GO:0060612) |
0.6 | 1.7 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.6 | 0.6 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.6 | 1.7 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.6 | 0.6 | GO:0042637 | catagen(GO:0042637) |
0.6 | 0.6 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.5 | 0.5 | GO:0044321 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.5 | 2.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.5 | 1.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.5 | 1.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.5 | 3.2 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.5 | 1.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.5 | 0.5 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.5 | 2.6 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.5 | 1.6 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.5 | 1.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.5 | 4.6 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.5 | 2.0 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.5 | 1.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.5 | 0.5 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.5 | 0.5 | GO:0044252 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.5 | 2.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.5 | 1.5 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.5 | 1.0 | GO:0045986 | relaxation of smooth muscle(GO:0044557) negative regulation of smooth muscle contraction(GO:0045986) relaxation of vascular smooth muscle(GO:0060087) |
0.5 | 4.0 | GO:0006108 | malate metabolic process(GO:0006108) |
0.5 | 1.5 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.5 | 1.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.5 | 1.5 | GO:0008354 | germ cell migration(GO:0008354) |
0.5 | 1.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.5 | 2.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.5 | 1.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.5 | 3.9 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.5 | 2.4 | GO:0090504 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.5 | 1.4 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.5 | 1.9 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.5 | 1.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.5 | 1.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.5 | 8.5 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.5 | 6.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.5 | 1.9 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.5 | 1.9 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.5 | 0.9 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.5 | 0.5 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.5 | 1.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.5 | 0.9 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.5 | 2.3 | GO:0015840 | urea transport(GO:0015840) |
0.5 | 10.5 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.5 | 1.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.4 | 1.8 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.4 | 2.7 | GO:0010225 | response to UV-C(GO:0010225) |
0.4 | 3.1 | GO:0007567 | parturition(GO:0007567) |
0.4 | 7.1 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.4 | 1.3 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.4 | 0.4 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.4 | 0.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.4 | 1.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.4 | 1.3 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.4 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 0.4 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.4 | 1.3 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.4 | 1.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 1.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.4 | 0.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 1.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.4 | 7.0 | GO:0048286 | lung alveolus development(GO:0048286) |
0.4 | 1.6 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.4 | 0.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.4 | 1.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 0.8 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.4 | 0.4 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.4 | 1.6 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.4 | 1.2 | GO:0032288 | myelin assembly(GO:0032288) |
0.4 | 0.4 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.4 | 0.4 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.4 | 1.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.4 | 0.4 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.4 | 4.0 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.4 | 0.8 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.4 | 0.8 | GO:0099518 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.4 | 0.4 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.4 | 0.4 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.4 | 1.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.4 | 1.5 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.4 | 0.8 | GO:0010159 | specification of organ position(GO:0010159) |
0.4 | 0.4 | GO:0003097 | renal water transport(GO:0003097) renal water absorption(GO:0070295) |
0.4 | 2.6 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.4 | 2.2 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
0.4 | 0.7 | GO:0032373 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.4 | 0.4 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.4 | 1.1 | GO:0042816 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.4 | 1.5 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.4 | 0.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 0.4 | GO:1903391 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) regulation of cell junction assembly(GO:1901888) regulation of adherens junction organization(GO:1903391) |
0.4 | 0.7 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.4 | 1.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 0.4 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.4 | 1.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 2.1 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.4 | 1.8 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.4 | 0.4 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.4 | 1.1 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.3 | 1.0 | GO:0070633 | transepithelial transport(GO:0070633) |
0.3 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.3 | 1.0 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.3 | 1.7 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.3 | 2.8 | GO:0030539 | male genitalia development(GO:0030539) |
0.3 | 1.7 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.3 | 0.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.3 | 2.1 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.3 | 1.4 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.3 | 1.0 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.3 | 0.7 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 0.7 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.3 | 2.7 | GO:0010092 | regulation of organ formation(GO:0003156) specification of organ identity(GO:0010092) |
0.3 | 1.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.3 | 0.3 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.3 | 0.3 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.3 | 0.3 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) sodium ion transmembrane transport(GO:0035725) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.3 | 1.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 2.0 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 0.7 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 1.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 1.0 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.3 | 4.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.3 | 1.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 1.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.3 | 1.0 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.3 | 2.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.3 | 1.3 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 1.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.3 | 1.0 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.3 | 0.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.3 | 1.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.3 | 0.6 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 0.6 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.3 | 1.6 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 1.6 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.3 | 0.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 1.2 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.3 | 0.9 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.3 | 0.3 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.3 | 0.6 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.3 | 1.5 | GO:0016246 | RNA interference(GO:0016246) |
0.3 | 0.9 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.3 | 0.9 | GO:0006562 | proline catabolic process(GO:0006562) |
0.3 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 6.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 | 0.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 0.3 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.3 | 3.9 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.3 | 0.6 | GO:0045924 | regulation of female receptivity(GO:0045924) female mating behavior(GO:0060180) |
0.3 | 4.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 0.9 | GO:0007494 | midgut development(GO:0007494) |
0.3 | 1.2 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.3 | 1.5 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.3 | 0.3 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.3 | 2.9 | GO:0007520 | myoblast fusion(GO:0007520) |
0.3 | 0.6 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.3 | 1.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.3 | 3.2 | GO:0033280 | response to vitamin D(GO:0033280) |
0.3 | 0.9 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.3 | 0.6 | GO:0010224 | response to UV-B(GO:0010224) |
0.3 | 1.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.3 | 0.3 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.3 | 2.0 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.3 | 0.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 0.3 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.3 | 2.3 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.3 | 2.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.3 | 0.8 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.3 | 0.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.3 | 0.6 | GO:0007431 | salivary gland development(GO:0007431) |
0.3 | 1.9 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 0.6 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.3 | 0.5 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.3 | 1.1 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.3 | 0.3 | GO:0048840 | otolith development(GO:0048840) |
0.3 | 1.6 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.3 | 0.3 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.3 | 0.8 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.8 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.3 | 3.7 | GO:0008272 | sulfate transport(GO:0008272) |
0.3 | 1.6 | GO:0015824 | proline transport(GO:0015824) |
0.3 | 0.3 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.3 | 1.1 | GO:0043276 | anoikis(GO:0043276) |
0.3 | 1.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 3.4 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.3 | 1.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 1.0 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.3 | 1.0 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.3 | 0.8 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.3 | 1.5 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.3 | 1.3 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.3 | 1.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.3 | 0.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 2.5 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.2 | 1.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 1.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 2.7 | GO:0006693 | prostaglandin metabolic process(GO:0006693) |
0.2 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.7 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.2 | 1.9 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.2 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 0.7 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.2 | 0.5 | GO:0043084 | penile erection(GO:0043084) |
0.2 | 0.2 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.2 | 1.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.2 | 0.2 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.2 | 0.5 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.2 | 0.7 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.2 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 0.2 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.2 | 0.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 4.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 1.4 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.2 | 0.7 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 0.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 0.7 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 0.9 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.2 | 0.7 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.2 | 1.1 | GO:0051135 | regulation of NK T cell activation(GO:0051133) positive regulation of NK T cell activation(GO:0051135) |
0.2 | 0.2 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.2 | 0.7 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 0.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 1.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.2 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
0.2 | 0.2 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.2 | 0.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 1.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.9 | GO:0007549 | dosage compensation(GO:0007549) |
0.2 | 0.2 | GO:0030728 | ovulation(GO:0030728) |
0.2 | 0.4 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.2 | 0.2 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.2 | 1.3 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.2 | 0.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 1.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.6 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 1.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.2 | 0.2 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.2 | 0.6 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.2 | 1.3 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.2 | 3.2 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.2 | 1.1 | GO:0071451 | removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.2 | 1.0 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.2 | 0.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 0.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 1.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 0.2 | GO:0072193 | positive regulation of smooth muscle cell differentiation(GO:0051152) ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.2 | 0.6 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.4 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.2 | 0.2 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.2 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.2 | GO:0030903 | notochord development(GO:0030903) |
0.2 | 0.2 | GO:0060872 | semicircular canal development(GO:0060872) |
0.2 | 9.0 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.2 | 0.4 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 0.4 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.2 | 0.8 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.2 | 0.6 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.2 | 1.0 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 1.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 0.6 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.2 | 0.8 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 0.8 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 0.4 | GO:0001660 | fever generation(GO:0001660) |
0.2 | 0.8 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 0.6 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.2 | 1.0 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.2 | 0.6 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.2 | 0.6 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.2 | 0.4 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.2 | 0.7 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 0.7 | GO:0030325 | adrenal gland development(GO:0030325) |
0.2 | 1.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.2 | 0.2 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.2 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.2 | 0.2 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.2 | 1.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.2 | 0.3 | GO:0042640 | anagen(GO:0042640) |
0.2 | 0.9 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.5 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.2 | 0.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.2 | 2.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.5 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.2 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.2 | 0.3 | GO:0034694 | response to prostaglandin(GO:0034694) response to prostaglandin E(GO:0034695) |
0.2 | 6.6 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.2 | 1.0 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.2 | 0.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 0.7 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.2 | 0.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.8 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.2 | 0.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 0.3 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 0.5 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.2 | 1.3 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 1.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.2 | 0.2 | GO:0060013 | reflex(GO:0060004) righting reflex(GO:0060013) |
0.2 | 0.2 | GO:0021756 | striatum development(GO:0021756) |
0.2 | 1.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.8 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.2 | 0.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 0.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 1.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 0.9 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) positive regulation of calcium ion import(GO:0090280) |
0.2 | 0.6 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.2 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 1.5 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 2.5 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 0.3 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.3 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 1.2 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.1 | 0.4 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.3 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.6 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.1 | 0.7 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.4 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.4 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.1 | 0.4 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 3.1 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.4 | GO:0048799 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.1 | 0.3 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.3 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.7 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 10.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.7 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.7 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 1.8 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.1 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 0.3 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 0.5 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 3.7 | GO:0051271 | negative regulation of cellular component movement(GO:0051271) |
0.1 | 0.8 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.8 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.1 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.1 | 0.4 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 1.0 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.7 | GO:0008207 | C21-steroid hormone metabolic process(GO:0008207) |
0.1 | 1.5 | GO:0038061 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.7 | GO:0021983 | pituitary gland development(GO:0021983) |
0.1 | 0.5 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 0.5 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.1 | 1.1 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.1 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.1 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.7 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.8 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 1.2 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 1.0 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) regulation of cellular response to insulin stimulus(GO:1900076) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 1.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.3 | GO:0051883 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.1 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.3 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.2 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.1 | 0.2 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.1 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.2 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.1 | 0.5 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.1 | 0.3 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 0.1 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 1.0 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.1 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.1 | 0.4 | GO:0030878 | thyroid gland development(GO:0030878) |
0.1 | 1.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.8 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.1 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 1.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.8 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.1 | 0.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.7 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.3 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.3 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.1 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 0.2 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.8 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 1.4 | GO:0003205 | cardiac chamber development(GO:0003205) |
0.1 | 0.2 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.4 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 9.3 | GO:0008544 | epidermis development(GO:0008544) |
0.1 | 0.4 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.1 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.9 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.2 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.1 | 1.6 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.1 | 0.5 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.1 | 0.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.1 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.1 | 1.0 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.1 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.1 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.1 | 0.8 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.1 | 0.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.1 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.1 | 0.3 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.1 | 0.1 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 0.1 | GO:0009651 | response to salt stress(GO:0009651) |
0.1 | 1.6 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.1 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.1 | 0.1 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.1 | 0.2 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.1 | 1.1 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.1 | 0.5 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.4 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.2 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.5 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.4 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 1.0 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.3 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.1 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.1 | 0.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.1 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.1 | 0.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.3 | GO:0006623 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.1 | 0.1 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.1 | 0.3 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.1 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.2 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.1 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.2 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.1 | 0.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.2 | GO:0016265 | obsolete death(GO:0016265) |
0.1 | 0.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 1.3 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.1 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.0 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.0 | 0.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.0 | 0.1 | GO:0070841 | inclusion body assembly(GO:0070841) |
0.0 | 0.7 | GO:0051789 | obsolete response to protein(GO:0051789) |
0.0 | 0.0 | GO:0051303 | chromosome localization(GO:0050000) establishment of chromosome localization(GO:0051303) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.0 | 0.1 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.0 | 0.3 | GO:0044247 | glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.1 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.0 | 0.1 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.0 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.1 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.0 | 0.0 | GO:0019755 | one-carbon compound transport(GO:0019755) |
0.0 | 1.5 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.0 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.0 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.0 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 1.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.0 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.2 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.1 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.0 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.1 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.1 | GO:0061515 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 0.1 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.4 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.0 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.3 | GO:0016358 | dendrite development(GO:0016358) |
0.0 | 0.1 | GO:0042490 | mechanoreceptor differentiation(GO:0042490) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.1 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.2 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.0 | 0.0 | GO:0032461 | regulation of protein oligomerization(GO:0032459) positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.4 | GO:0036503 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.0 | 0.0 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0014808) calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
0.0 | 0.0 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.0 | 0.1 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.0 | 0.0 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.0 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 2.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.4 | 4.2 | GO:0032449 | CBM complex(GO:0032449) |
1.4 | 4.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
1.3 | 3.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.2 | 8.6 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
1.2 | 6.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.2 | 7.2 | GO:0005915 | zonula adherens(GO:0005915) |
1.2 | 8.3 | GO:0002102 | podosome(GO:0002102) |
1.1 | 4.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.9 | 2.7 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.9 | 2.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.9 | 5.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.8 | 3.3 | GO:0032059 | bleb(GO:0032059) |
0.8 | 2.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.8 | 6.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.7 | 3.0 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.7 | 3.7 | GO:0016342 | catenin complex(GO:0016342) |
0.7 | 3.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.7 | 4.4 | GO:0001527 | microfibril(GO:0001527) |
0.7 | 0.7 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.7 | 0.7 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.6 | 0.6 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.6 | 3.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.6 | 0.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.6 | 2.9 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.5 | 1.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.5 | 1.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.5 | 3.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.5 | 3.6 | GO:0043256 | laminin complex(GO:0043256) |
0.5 | 2.0 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.5 | 1.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.5 | 2.8 | GO:0031430 | M band(GO:0031430) |
0.5 | 13.0 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.5 | 2.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 1.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.4 | 4.6 | GO:0030315 | T-tubule(GO:0030315) |
0.4 | 2.3 | GO:0010369 | chromocenter(GO:0010369) |
0.4 | 19.9 | GO:0030426 | growth cone(GO:0030426) |
0.4 | 0.4 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.4 | 7.1 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 3.0 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.4 | 2.6 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 16.0 | GO:0005604 | basement membrane(GO:0005604) |
0.4 | 0.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.4 | 2.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.4 | 2.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) complex of collagen trimers(GO:0098644) |
0.4 | 73.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.3 | 2.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 5.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 1.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 6.0 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 1.5 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 15.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.3 | 3.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.3 | 0.9 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.3 | 0.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.3 | 0.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 1.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 2.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 1.2 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.3 | 25.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.3 | 0.9 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 0.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 1.1 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.3 | 20.1 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.3 | 4.7 | GO:0005912 | adherens junction(GO:0005912) |
0.3 | 0.3 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.3 | 0.8 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.3 | 2.0 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.3 | 15.4 | GO:0030017 | sarcomere(GO:0030017) |
0.2 | 1.5 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.2 | 13.5 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 1.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.2 | 1.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 2.7 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.2 | 0.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.7 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.2 | 0.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 1.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 2.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 1.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 1.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 0.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 0.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 1.2 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.2 | 0.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.6 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.2 | 0.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 1.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 9.3 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 1.4 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 1.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 1.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 2.0 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.2 | 1.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 4.0 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 1.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 1.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 2.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.6 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.7 | GO:0000801 | central element(GO:0000801) |
0.1 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 2.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 1.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 1.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 3.1 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 9.8 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 1.8 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 2.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.3 | GO:0044421 | extracellular region part(GO:0044421) |
0.1 | 1.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.4 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.2 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 1.3 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.1 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 1.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 1.1 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.5 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.6 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.9 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 1.3 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 2.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 5.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.2 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.1 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.1 | 0.7 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 1.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.9 | GO:0097223 | sperm part(GO:0097223) |
0.0 | 17.9 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 1.0 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.7 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 0.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0045277 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 1.9 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.7 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.0 | 0.9 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.3 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.7 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 0.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.0 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.0 | 0.3 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.3 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
2.0 | 6.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
2.0 | 15.8 | GO:0017166 | vinculin binding(GO:0017166) |
1.9 | 7.7 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
1.8 | 10.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.6 | 1.6 | GO:0043559 | insulin binding(GO:0043559) |
1.4 | 5.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.4 | 4.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.4 | 5.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.4 | 2.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
1.3 | 4.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
1.3 | 5.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
1.3 | 3.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.2 | 6.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
1.2 | 3.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.2 | 3.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.2 | 5.8 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
1.2 | 3.5 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
1.1 | 3.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.1 | 7.7 | GO:0005110 | frizzled-2 binding(GO:0005110) |
1.0 | 3.1 | GO:0045545 | syndecan binding(GO:0045545) |
1.0 | 7.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.0 | 5.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
1.0 | 1.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
1.0 | 4.0 | GO:0004470 | malic enzyme activity(GO:0004470) |
1.0 | 2.9 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
1.0 | 2.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.9 | 2.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.9 | 2.7 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.9 | 7.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.9 | 0.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.8 | 2.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.8 | 2.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.8 | 2.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.8 | 3.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.8 | 7.3 | GO:0005112 | Notch binding(GO:0005112) |
0.8 | 3.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.8 | 7.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.8 | 2.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.8 | 3.1 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.8 | 3.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.7 | 4.5 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.7 | 5.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.7 | 2.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.7 | 2.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.7 | 6.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.7 | 2.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.7 | 3.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.7 | 2.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.7 | 2.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.7 | 2.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.7 | 2.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.7 | 4.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.7 | 2.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.7 | 2.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.7 | 2.7 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.7 | 2.6 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.7 | 4.6 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.7 | 2.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.7 | 3.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.6 | 1.9 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.6 | 2.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.6 | 3.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.6 | 3.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.6 | 3.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.6 | 2.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.6 | 1.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.6 | 1.8 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.6 | 1.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.6 | 1.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.6 | 2.3 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.6 | 2.3 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 1.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.5 | 0.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.5 | 2.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.5 | 12.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.5 | 5.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.5 | 1.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 2.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 4.0 | GO:0030371 | translation repressor activity(GO:0030371) |
0.5 | 4.9 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.5 | 3.9 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.5 | 0.5 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.5 | 7.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.5 | 4.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 6.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 2.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.5 | 2.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.5 | 4.7 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.5 | 32.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.5 | 1.4 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.5 | 4.5 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.5 | 7.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.4 | 1.3 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.4 | 2.2 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.4 | 1.8 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.4 | 1.3 | GO:0046980 | tapasin binding(GO:0046980) |
0.4 | 1.3 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.4 | 1.7 | GO:0032190 | acrosin binding(GO:0032190) |
0.4 | 2.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 1.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.4 | 1.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.4 | 0.8 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.4 | 1.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.4 | 2.1 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.4 | 2.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 4.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.4 | 1.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.4 | 1.6 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.4 | 3.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.4 | 2.8 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 3.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 1.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 1.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 17.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.4 | 0.8 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.4 | 0.4 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 1.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.4 | 1.5 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.4 | 5.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.4 | 1.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.4 | 3.3 | GO:0048038 | quinone binding(GO:0048038) |
0.4 | 1.5 | GO:0045569 | TRAIL binding(GO:0045569) |
0.4 | 1.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.4 | 1.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.3 | 0.7 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.3 | 3.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 1.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 1.3 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 1.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 2.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 1.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 1.7 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 1.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 3.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 2.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.3 | 1.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.3 | 1.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 0.9 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 3.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.3 | 0.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 2.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.3 | 2.1 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.3 | 0.9 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.3 | 0.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 0.9 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.3 | 1.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 0.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 0.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 3.9 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.3 | 0.9 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 0.9 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 0.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 0.3 | GO:0015184 | sulfur amino acid transmembrane transporter activity(GO:0000099) L-cystine transmembrane transporter activity(GO:0015184) |
0.3 | 1.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 6.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 1.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.3 | 1.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 1.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 4.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 1.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 1.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.3 | 0.8 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.3 | 0.8 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.3 | 1.3 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.3 | 0.8 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.3 | 0.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 0.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 0.8 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.3 | 1.0 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.3 | 1.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.3 | 0.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 5.2 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 2.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.2 | 0.7 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.2 | 0.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 4.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 1.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 1.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.2 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 0.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 1.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 2.1 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 1.1 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.2 | 0.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 0.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 1.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 1.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.6 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.2 | 2.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 1.4 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.2 | 3.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 0.6 | GO:0004340 | glucokinase activity(GO:0004340) |
0.2 | 1.0 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 1.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 1.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 1.6 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 0.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 1.0 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.2 | 2.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 1.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 3.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 2.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.2 | 0.7 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.2 | 1.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 2.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 1.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 0.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 2.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 13.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 1.1 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.2 | 3.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 1.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.2 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.2 | 0.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.2 | 2.5 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 0.7 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.2 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 1.7 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.2 | 0.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 10.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.3 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.2 | 0.5 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.2 | 0.5 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 2.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 1.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 2.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.9 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.2 | 0.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 2.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 0.3 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 2.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 0.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.9 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 14.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.4 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 1.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.5 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 1.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 5.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 1.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 1.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 1.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.5 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 5.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.4 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.3 | GO:0034648 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 1.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.6 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 0.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.9 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 1.1 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 1.6 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 0.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.3 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 1.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.8 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 4.9 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 0.5 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.4 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.7 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.9 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.1 | 0.7 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.1 | 0.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 1.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.8 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 8.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 1.2 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.1 | 0.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 1.1 | GO:0042562 | hormone binding(GO:0042562) |
0.1 | 0.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 1.9 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 1.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.1 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.1 | 1.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.5 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.4 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 1.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.1 | 0.9 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.6 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.1 | 0.2 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.2 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.1 | GO:0000987 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.1 | 0.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.7 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 6.3 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.6 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.8 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.0 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.5 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.1 | GO:0080031 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.0 | 0.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 1.0 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.0 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.0 | 0.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 1.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.1 | 11.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
1.0 | 2.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.8 | 2.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.8 | 17.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.7 | 28.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.6 | 8.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 0.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.5 | 20.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.5 | 12.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 2.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.4 | 3.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 15.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 0.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 5.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 55.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 0.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 14.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 7.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 0.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 5.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 4.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 4.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 0.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 4.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 1.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 6.0 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 6.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 8.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 6.1 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.2 | 3.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 39.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 1.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 0.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 4.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 3.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 3.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 1.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 4.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 2.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 1.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 1.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 2.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 2.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 6.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 14.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.9 | 0.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.9 | 19.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.8 | 11.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.8 | 0.8 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.7 | 9.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.7 | 0.7 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.6 | 10.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.6 | 17.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.6 | 11.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.6 | 32.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.5 | 5.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.5 | 8.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 0.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.5 | 9.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.5 | 14.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.5 | 2.7 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.5 | 5.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 0.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.4 | 3.5 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.4 | 9.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 0.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.4 | 3.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.4 | 3.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 5.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.4 | 0.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.4 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 0.3 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.3 | 3.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 7.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 0.3 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.3 | 2.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 2.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 3.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 2.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 7.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.3 | 0.8 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.3 | 1.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 2.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 9.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.3 | 0.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 3.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 1.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 5.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 1.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 2.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 2.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 2.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 4.6 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.2 | 1.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 1.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 1.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 2.6 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 2.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 0.4 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.2 | 2.3 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.2 | 0.9 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 0.4 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.2 | 4.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.2 | 3.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 0.8 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 0.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.2 | 0.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 1.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 0.2 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.2 | 3.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 2.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 1.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 4.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 2.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 2.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 1.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 2.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 1.5 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 1.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 2.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 2.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.9 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 1.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 8.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 1.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 2.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 4.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 1.2 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.5 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 5.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 2.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 1.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 1.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |